8-K: Synergy CHC Reports 10th Consecutive Profitable Quarter

Synergy CHC Corp. announced its tenth consecutive quarter of profitability, driven by revenue growth, improved gross margins, and strategic expansions.

Summary

• Achieved its tenth consecutive quarter of profitability.
• Reported Q2 2025 revenue of $8.1 million, a 1% increase from $8.0 million in Q2 2024, primarily driven by $1.4 million in license revenue.
• Gross margin improved significantly to 76.7% in Q2 2025, up from 69.5% in Q2 2024.
• Net income for Q2 2025 was $1.5 million, a 125% increase compared to $655.2 thousand in Q2 2024.
• Earnings per share (EPS) for Q2 2025 was $0.17, an 86% increase from $0.09 in Q2 2024.
• EBITDA, a non-GAAP measure, reached $3.80 million in Q2 2025, up 136% from $1.61 million in Q2 2024.
• Successfully completed a $20 million debt refinancing, entering into a term loan credit agreement due May 2029, with $17.5 million drawn.
• Expanded the global footprint of the FOCUSfactor brand through a licensing agreement in Turkey.
• Secured major North American retail and distribution wins for its supplement and beverage lines, expected to yield significant results in Q4 2025.
• Reduced outstanding liabilities by $869 thousand during Q2 2025 and an additional $1.8 million in notes payable subsequent to quarter end.
• Shifted from a working capital deficit of $1.12 million as of December 31, 2024, to a working capital surplus of $12.4 million as of June 30, 2025.
• Cash and cash equivalents increased to $1.5 million as of June 30, 2025, from $687.9 thousand as of December 31, 2024.

Sentiment

Score: 8

Explanation: The filing presents strong financial improvements across key metrics like net income, EBITDA, and gross margin, coupled with strategic achievements such as debt refinancing and market expansion. While operating expenses increased and product sales revenue declined, the overall picture is positive due to the significant growth in profitability and improved financial structure.

Positives

• Achieved its tenth consecutive quarter of profitability.
• Reported year-over-year growth in revenue, gross profit, net income, and earnings per share.
• Gross margin significantly increased to 76.7% in Q2 2025, up from 69.5% in Q2 2024, largely driven by license revenue.
• Net income surged by 125% to $1.5 million in Q2 2025.
• EBITDA increased by 136% to $3.80 million in Q2 2025.
• Successfully completed a $20 million debt refinancing, extending the maturity profile to May 2029 and enhancing financial flexibility.
• Expanded the FOCUSfactor brand internationally through a new licensing agreement in Turkey.
• Secured significant North American retail and distribution partnerships for its supplement and beverage lines.
• Reduced outstanding liabilities by $869 thousand in Q2 2025 and an additional $1.8 million in notes payable post-quarter end.
• Improved working capital position from a $1.12 million deficit to a $12.4 million surplus.
• Increased cash and cash equivalents to $1.5 million.

Negatives

• Operating expenses increased by 16% to $4.6 million in Q2 2025, driven by incremental costs associated with being a public company.
• Product sales revenue decreased to $6.7 million in Q2 2025 from $8.0 million in Q2 2024, with overall revenue growth attributed to license revenue.
• Interest expense significantly increased to $2.11 million in Q2 2025 from $0.74 million in Q2 2024.

Risks

• Forward-looking statements are subject to risks, uncertainties, and other factors outlined in Synergy's registration statement on Form S-1, as amended.
• Actual results could differ materially from forward-looking statements due to factors outside of Synergy's control.
• Synergy does not undertake any obligation to update or revise forward-looking statements, except as required by law.
• New factors emerge over time, and it is not possible for Synergy to predict all such factors.

Future Outlook

The company is well-positioned to accelerate growth in the second half of 2025 and beyond, supported by an improved capital structure and continued momentum. Major North American retail and distribution wins are expected to yield significant results in the fourth quarter of 2025.

Management Comments

• "We are pleased to report another strong quarter, marking our tenth consecutive quarter of profitability." Jack Ross, CEO.
• "Revenue, gross profit, net income and earnings per share all grew year-over-year, reflecting our continued focus on disciplined execution and profitable growth." Jack Ross, CEO.
• "We also made significant progress across our strategic priorities, including expanding the global footprint of our FOCUSfactor brand through a licensing agreement in Turkey." Jack Ross, CEO.
• "On the beverage side, our new leadership team is already driving results, securing distribution partners across North America and advancing the growth of our RTD business." Jack Ross, CEO.
• "In addition, we successfully completed a $20 million debt refinancing, which is a significant milestone for the company. It extends our maturity profile, enhances financial flexibility and supports our long-term growth strategy." Jack Ross, CEO.
• "With this improved capital structure and continued momentum, we’re well positioned to accelerate growth in the second half of 2025 and beyond." Jack Ross, CEO.

Industry Context

Synergy CHC Corp. operates in the consumer health and wellness sector, focusing on brain health supplements (FOCUSfactor), women's wellness/weight management (Flat Tummy), and ready-to-drink (RTD) beverages. The company's strategic moves, including international licensing and expanded North American distribution, indicate a strong push for market penetration and diversification within the growing health and wellness industry. The increase in license revenue suggests a successful strategy to monetize intellectual property and brand recognition.

Comparison to Industry Standards

• NA

Management Changes

Related Party Transactions

• Loan receivable (related party) of $4,427,883 as of June 30, 2025.
• Prepaid expenses include related party amounts of $801,345 as of June 30, 2025.
• Accounts payable and accrued liabilities include payable to shareholder of $92,955 as of June 30, 2025.
• Advances from related party of $135,000 for the six months ended June 30, 2025.
• Repayment of notes payable, related party of $135,000 for the six months ended June 30, 2025.
• Issuance of pre-funded warrants for settlement of shareholder notes payable of $899,993.

Stakeholder Impact

• Shareholders: Positive impact due to increased profitability, EPS growth, improved financial flexibility, and strategic expansions, potentially leading to increased share value.
• Creditors: Positive impact due to debt refinancing extending maturity and improving the capital structure, reducing immediate repayment pressure.
• Employees: Positive impact due to company growth and expansion, potentially leading to job security and opportunities, especially with new leadership in the beverage division.
• Customers: Positive impact due to expanded availability of products through new distribution channels.
• Suppliers: Potential positive impact from increased demand due to expanded distribution.

Next Steps

• Accelerate growth in the second half of 2025 and beyond.
• North American retail and distribution wins are expected to yield significant results in the fourth quarter of 2025.
• Host a conference call on August 14, 2025, to discuss the financial results.

Key Dates

Recommendation

The company has demonstrated consistent profitability, significant year-over-year growth in key financial metrics (net income, EBITDA, gross margin), and a substantial improvement in its balance sheet through successful debt refinancing and working capital management. Strategic initiatives like international licensing and North American distribution expansion provide clear growth catalysts. Despite an increase in operating expenses and a decline in product sales (offset by license revenue), the overall financial health and strategic direction indicate strong positive momentum, making it an attractive investment.

Keywords

Consumer health, wellness, supplements, FOCUSfactor, Flat Tummy, RTD beverages, financial results, profitability, debt refinancing, licensing, distribution, NASDAQ: SNYR